Back
MoonLake Immunotherapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
39
MLTX
MoonLake Immunotherapeutics
Last Price:
46.48
Seasonality Move:
18.28%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47 | Sell |
| 20-day SMA: | 48.43 | Sell |
| 50-day SMA: | 49.19 | Sell |
| 200-day SMA: | 47.35 | Sell |
| 8-day EMA: | 47.23 | Sell |
| 20-day EMA: | 48.16 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 46.78 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.82 | Sell |
| Relative Strength Index (14 RSI): | 43.6 | Sell |
| Chaikin Money Flow: | 51270 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.8 - 51.14) | Sell |
| Bollinger Bands (100): | (42.72 - 50.4) | Buy |
MoonLake Immunotherapeutics Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 46.76 while MLTX 8-day simple moving average is 47.00, which is a Sell signal.
- The stock price of MLTX is 46.76 while MoonLake Immunotherapeutics 20-day SMA is 48.43, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day simple moving average is 49.19 while MLTX share price is 46.76, making it a Sell technically.
- MLTX stock price is 46.76 and MoonLake Immunotherapeutics 200-day simple moving average is 47.35, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
39
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Sell
The current MoonLake Immunotherapeutics [MLTX] share price is $46.76. The Score for MLTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
2.94B
Price in USD:
46.76
Share Volume:
244.05K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
35.11
Sell
39
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?
The MoonLake Immunotherapeutics stock price is 46.76 USD today. -
Will MLTX stock go up or go down?
MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is MoonLake Immunotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 46.76 while MLTX 8-day exponential moving average is 47.23, which is a Sell signal.
- The stock price of MLTX is 46.76 while MoonLake Immunotherapeutics 20-day EMA is 48.16, which makes it a Sell.
- MoonLake Immunotherapeutics 50-day exponential moving average is 48.36 while MLTX share price is 46.76, making it a Sell technically.
- MLTX stock price is 46.76 and MoonLake Immunotherapeutics 200-day simple moving average is 46.78, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.61 per share, and a decrease next year of $0.76 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
- MLTX Moving Average Covergence Divergence (MACD) indicator is -0.82, suggesting MoonLake Immunotherapeutics is a Sell
- MoonLake Immunotherapeutics Relative Strength Index (RSI) is 43.6, which suggest MoonLake Immunotherapeutics is oversold
- The Bollinger Bands (25) for MoonLake Immunotherapeutics is (46.8 - 51.14), which suggest MoonLake Immunotherapeutics is a Buy
- The Bollinger Bands (100) for MoonLake Immunotherapeutics is (42.72 - 50.4), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.